Enterprise Financial Services Corp maintained its stake in Clorox Co. (NYSE:CLX) during the second quarter, according to its most recent filing with the SEC. The fund owned 4,143 shares of the company’s stock at the end of the second quarter. Enterprise Financial Services Corp’s holdings in Clorox were worth $573,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the company. Checchi Capital Advisers LLC boosted its stake in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock valued at $113,000 after buying an additional 8 shares during the period. Cleararc Capital Inc. boosted its stake in Clorox by 0.3% in the first quarter. Cleararc Capital Inc. now owns 3,163 shares of the company’s stock valued at $399,000 after buying an additional 10 shares during the period. Mariner Wealth Advisors LLC boosted its stake in Clorox by 0.4% in the first quarter. Mariner Wealth Advisors LLC now owns 2,505 shares of the company’s stock valued at $316,000 after buying an additional 10 shares during the period. Keel Point LLC boosted its stake in Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock valued at $1,040,000 after buying an additional 37 shares during the period. Finally, Savant Capital LLC boosted its stake in Clorox by 3.2% in the second quarter. Savant Capital LLC now owns 2,551 shares of the company’s stock valued at $353,000 after buying an additional 80 shares during the period. Institutional investors own 70.20% of the company’s stock.
Shares of Clorox Co. (NYSE:CLX) traded down 0.81% during midday trading on Wednesday, hitting $120.81. 1,247,338 shares of the stock were exchanged. The stock’s 50-day moving average price is $124.81 and its 200 day moving average price is $129.64. Clorox Co. has a one year low of $119.23 and a one year high of $140.47. The stock has a market cap of $15.64 billion, a P/E ratio of 24.55 and a beta of 0.29.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.28 by $0.02. The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The firm’s revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.44 EPS. On average, analysts anticipate that Clorox Co. will post $5.49 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be given a dividend of $0.80 per share. The ex-dividend date is Monday, October 24th. This represents a $3.20 annualized dividend and a dividend yield of 2.65%. Clorox’s dividend payout ratio is currently 64.91%.
Several research firms have recently commented on CLX. B. Riley restated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research note on Tuesday, August 9th. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th. Goldman Sachs Group Inc. reiterated a “neutral” rating and issued a $130.00 price objective on shares of Clorox in a research note on Thursday, August 4th. Citigroup Inc. raised their price objective on shares of Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Finally, Jefferies Group reiterated a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $127.80.
In related news, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction dated Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. Insiders own 0.74% of the company’s stock.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.